Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2018
February 15, 2019 at 03:02 am IST
Share
Remedent, Inc. announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced sales was USD 419,326 compared to USD 745,103 a year ago. Operating loss was USD 222,377 compared to USD 23,278 a year ago. Net loss was USD 187,753 compared to net income of USD 52,139 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to Basic EPS - Continuing Operations of USD 0 a year ago. For the nine months, sales was USD 1.199 million compared to USD 2.215 million a year ago. Operating loss was USD 491,607 compared to USD 62,294 a year ago. Net loss was USD 422,669 compared to net income of USD 164,298 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to basic earnings per share from continuing operations of USD 0.01 a year ago.
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
REMEDENT, INC. 